#biopharmaceuticalcompany — Public Fediverse posts

Is Sanofi (SNY) One of the Best Affordable Blue Chip Stocks to Buy Now?

Sanofi (NASDAQ:SNY) is included among the 10 Best Affordable Blue Chip Stocks to Buy Now. Is Sanofi (SNY)…
#France #FR #Europe #EU #Sanofi #biopharmaceuticalcompany #BlueChipStocks #GrahamParry #therapeuticsolutions
https://www.europesays.com/france/21928/

BNP Paribas Downgrades Sanofi (SNY) with ‘Unlikely Near-Term Rerating’

Sanofi (NASDAQ:SNY) is included among the 10 Best Global Stocks to Buy According to Wall Street Analysts. BNP…
#France #FR #Europe #EU #Sanofi #biopharmaceuticalcompany #BNPParibas #WallStreetAnalysts
https://www.europesays.com/france/19660/

European Growth Stocks Backed By High Insider Ownership

The European market has experienced a week of volatility, with the pan-European STOXX Europe 600 Index achieving modest…
#Europe #EU #biopharmaceuticalcompany #EarningsGrowth #EnvipcoHolding #Europeanmarket #growthcompanies #growthprospects #insiderownership #LimeTechnologies #SemperitAktiengesellschaftHolding
https://www.europesays.com/europe/40355/

Asahi Kasei acquires German company Aicuris

Asahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company. The move comes after…
#Germany #DE #Europe #EU #Europa #AsahiKasei #biopharmaceuticalcompany #clinicaldevelopment #definitiveagreement #immunocompromisedpatients #issuedshares #pharmaceuticaltreatments #VeloxisPharmaceuticals
https://www.europesays.com/germany/6246/

https://www.europesays.com/ch/49619/ Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting #Allschwil #AnneWhitaker #AnnualGeneralMeeting #BacterialInfections #Basel #BasileaPharmaceutica #BiopharmaceuticalCompany #FinancialStatements #NicoleOnetto #shareholders #StephanSchindler #TheBoardOfDirectors

European Growth Stocks Insiders Are Eager To Own

As European markets rally following a U.S.-Iran ceasefire, with the STOXX Europe 600 Index climbing over 3%, investor…
#Europe #EU #biopharmaceuticalcompany #EarningsGrowth #European #Europeanmarkets #growthcompanies #insiderownership #NewronPharmaceuticals #SemperitAktiengesellschaftHolding #STOXXEurope600 #VerveGroup
https://www.europesays.com/europe/13713/

European Growth Stocks Insiders Are Betting On

As European markets rally on the back of a U.S.-Iran ceasefire, investor sentiment has been buoyed by optimism…
#Europe #EU #biopharmaceuticalcompany #EarningsGrowth #European #Europeanmarkets #EuropeanMedicinesAgency #growthcompanies #insiderownership #MarketCap #pharmaceuticalcompany #revenuegrowth
https://www.europesays.com/europe/13370/

European Growth Stocks Insiders Are Betting On

As European markets rally on the back of a U.S.-Iran ceasefire, investor sentiment has been buoyed by optimism…
#Europe #EU #biopharmaceuticalcompany #EarningsGrowth #European #Europeanmarkets #EuropeanMedicinesAgency #growthcompanies #insiderownership #MarketCap #pharmaceuticalcompany #revenuegrowth
https://www.europesays.com/europe/12918/

https://www.europesays.com/ch/46706/ Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420 #Allschwil #AntibacterialProducts #AntimicrobialResistance #BacterialInfections #Basel #BasileaPharmaceutica #BiopharmaceuticalCompany #ClinicalDevelopment #ClinicalStudy #development #FungalInfections #NovelAntibiotic #ProductDevelopment #ResearchAndDevelopment #WorldHealthOrganization

https://www.europesays.com/ie/414153/ Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs #BiopharmaceuticalCompany #DataMonitoringCommittee #DEEs #Development #Éire #FoodAndDrugAdministration #ForwardLookingStatements #Health #IE #Ireland #Medication #NDASubmission #OrphanDrugDesignation #PrescriptionDrugUserFeeAct #TargetedTherapies

Savara Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) for MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

— EMA Review of MOLBREEVI MAA Has Now Initiated, Decision Expected in Q1 2027 — — MOLBREEVI Bio…
#Europe #EU #alveolarmacrophages #AutoimmunePAP #biopharmaceuticalcompany #EMA #European #Forward-LookingStatements #GM-CSF #PAP #respiratorydiseases #Savara #SavaraInc. #surfactant
https://www.europesays.com/europe/982/

BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®

BioXcel Therapeutics Company remains focused on potential approval and lau…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #abnormalheartrhythm #acutetreatment #agitation #biopharmaceuticalcompany #bloodpressure #dexmedetomidine #foodanddrugadministration #Health #Healthcareprovider #patients #sideeffects #TheCompany #Therapeutics
https://www.newsbeep.com/us/394318/

BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®

BioXcel Therapeutics Company remains focused on potential approval and lau…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #abnormalheartrhythm #acutetreatment #agitation #biopharmaceuticalcompany #bloodpressure #dexmedetomidine #foodanddrugadministration #Health #Healthcareprovider #patients #sideeffects #TheCompany #Therapeutics
https://www.newsbeep.com/us/394318/

https://www.europesays.com/uk/680821/ BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI® #AbnormalHeartRhythm #AcuteTreatment #agitation #BiopharmaceuticalCompany #BloodPressure #dexmedetomidine #FoodAndDrugAdministration #Health #HealthCareProvider #Healthcare #patients #SideEffects #TheCompany #Therapeutics #UK #UnitedKingdom

BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®

BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute tr…
#NewsBeep #News #Healthcare #abnormalheartrhythm #acutetreatment #agitation #AU #Australia #biopharmaceuticalcompany #bloodpressure #dexmedetomidine #foodanddrugadministration #Health #healthcareprovider #patients #sideeffects #TheCompany #Therapeutics
https://www.newsbeep.com/au/398210/

BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®

BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® …
#NewsBeep #News #Healthcare #abnormalheartrhythm #acutetreatment #agitation #biopharmaceuticalcompany #bloodpressure #dexmedetomidine #foodanddrugadministration #Health #healthcareprovider #healthcare #Patients #sideeffects #TheCompany #Therapeutics #UK #UnitedKingdom
https://www.newsbeep.com/uk/357583/

Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

Milestone Phar…
#NewsBeep #News #Medication #Aptar #AptarPharma #biopharmaceuticalcompany #BusinessWire #CA #Canada #consumerproduct #foodanddrugadministration #Health #milestone #nasalspray #paroxysmalsupraventriculartachycardia #pharmaceuticals #protectiontechnologies #PSVT #sinusrhythm
https://www.newsbeep.com/ca/356064/

https://www.europesays.com/ie/241459/ Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT) #Aptar #AptarPharma #BiopharmaceuticalCompany #BUSINESSWIRE #ConsumerProduct #Éire #FoodAndDrugAdministration #Health #IE #Ireland #Medication #milestone #NasalSpray #ParoxysmalSupraventricularTachycardia #pharmaceuticals #ProtectionTechnologies #PSVT #SinusRhythm

Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

Milesto…
#NewsBeep #News #Medication #Aptar #AptarPharma #biopharmaceuticalcompany #BUSINESSWIRE #consumerproduct #foodanddrugadministration #Health #milestone #nasalspray #paroxysmalsupraventriculartachycardia #Pharmaceuticals #protectiontechnologies #PSVT #sinusrhythm #UK #UnitedKingdom
https://www.newsbeep.com/uk/324938/

Opus Genetics Appoints Rob Gagnon as Chief Financial Officer

Opus Genetics, Inc. Robert Gagnon, CFO, Opus Genetics Robert Gagnon, CFO, Opus Genetics RESEARCH TRI…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Genetics #biopharmaceuticalcompany #ChiefExecutiveOfficer #ChiefFinancialOfficer #clinicaldevelopment #clinicalprograms #genetherapies #GeorgeMagrath #HarvardBioscience #retinaldiseases #RobGagnon #RobertGagnon #Science #strategicfinance
https://www.newsbeep.com/us/127237/

Opus Genetics Appoints Rob Gagnon as Chief Financial Officer

Opus Genetics, Inc. Robert Gagnon, CFO, Opus Genetics Robert Gagnon, CFO, Opus Genetics RESEARCH TRI…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Genetics #biopharmaceuticalcompany #ChiefExecutiveOfficer #ChiefFinancialOfficer #clinicaldevelopment #clinicalprograms #genetherapies #GeorgeMagrath #HarvardBioscience #retinaldiseases #RobGagnon #RobertGagnon #Science #strategicfinance
https://www.newsbeep.com/us/127237/

https://www.europesays.com/uk/300551/ High Growth Tech Stocks To Watch In Europe July 2025 #BiopharmaceuticalCompany #BonesupportHolding #EarningsGrowth #EU #Europe #European #EuropeanCentralBank #InternationalMarkets #MarketSentiment #NicheMarket #PharmingGroup #RevenueGrowth #STOXXEurope600